Quality by digital design for accelerated sustainable nanomedicine development
European Journal of Pharmaceutical Sciences · 2025-10 · 213 · 107239
DOI: 10.1016/j.ejps.2025.107239 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Pharmaceutical Sciences, 2025-10. Verfasst von Yousef Ijjeh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cell Therapy Center, The University of Jordan, Amman, 11942, Jordan. Hauptthemen laut MEDLINE: Nanomedicine, Nanoparticles. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 258 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Drug delivery systems, diagnostics, and treatments are all being revolutionized by nanomedicine, greatly improving contemporary healthcare. However, traditional nanomedicine development relies on extensive experimental testing, which is costly, time-consuming, and environmentally harmful. To address these challenges, the Quality by Digital Design (QbDD) concept and framework have been developed, integrating digital technologies such as substantial data analytics, Artificial Intelligence (AI), Machine Learning (ML), and computational modeling to transform nanoparticle design. QbDD enables smart digital simulations and predictive analytics to improve nanoparticles with precise bio-physicochemical properties, thereby enhancing batch reproducibility while reducing reliance on resource-intensive physical experiments, lowering costs, and minimizing environmental impact. This digital infrastructure not only optimizes nanoparticle design and efficacy but also ensures compliance with regulatory standards. This review examines the fundamentals of nano-informatics and its integration with QbDD in nanomedicine, focusing on AI-powered molecular simulations and in silico screening to pre-select nanoparticle candidates, thereby reducing dependence on labor-intensive experimental validation. Furthermore, it discusses digital innovations in nanopharmaceuticals, including real-time monitoring systems and digital twins for process verification, highlighting how these advancements enhance nanoparticle synthesis, making it more efficient, cost-effective, and sustainable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cell Therapy Center, The University of Jordan, Amman, 11942, Jordan.
- College of Medicine & Health Sciences. United Arab Emirates University, Al Ain, 15551, UAE.
- Pharmacological and Diagnostic Research Center, Al-Ahliyya Amman University, Amman, 19328, Jordan.
- Faculty of Pharmacy, Al-Ahliyya Amman University, Amman 19328, Jordan.
- Faculty of Pharmacy, The University of Jordan, Amman 11942, Jordan.
- Cell Therapy Center, The University of Jordan, Amman, 11942, Jordan; Pharmacological and Diagnostic Research Center, Al-Ahliyya Amman University, Amman, 19328, Jordan; Faculty of Allied Medical Sciences, Al-Ahliyya Amma…
Zitieren
APA
Ijjeh, Y., Alsarayreh, N., Rifai, A., Abdelnabi, H., Al-Mahamid, S., Alqudah, D. A., Nsairat, H., Lafi, Z., Mousa, M. A., Al-Hiari, Y., & Alshaer, W. (2025). Quality by digital design for accelerated sustainable nanomedicine development. European Journal of Pharmaceutical Sciences, 213, 107239. https://doi.org/10.1016/j.ejps.2025.107239
Vancouver
Ijjeh Y, Alsarayreh N, Rifai A, Abdelnabi H, Al-Mahamid S, Alqudah DA, et al. Quality by digital design for accelerated sustainable nanomedicine development. European Journal of Pharmaceutical Sciences. 2025;213:107239. doi:10.1016/j.ejps.2025.107239
BibTeX
@article{Ijjeh2025,
author = {Ijjeh, Yousef and Alsarayreh, Nowar and Rifai, Alaa and Abdelnabi, Hiba and Al-Mahamid, Sara and Alqudah, Dana A and Nsairat, Hamdi and Lafi, Zainab and Mousa, Mohamad Ak and Al-Hiari, Yusuf and Alshaer, Walhan},
title = {Quality by digital design for accelerated sustainable nanomedicine development},
journal = {European Journal of Pharmaceutical Sciences},
year = {2025},
volume = {213},
pages = {107239},
doi = {10.1016/j.ejps.2025.107239}
}
EUVIMED